Trial Profile
A Phase I Clinical Trial for BAT5906(single-dose;for injection) on Safety and Pharmacokinetics for Patients with Age-related macular degeneration
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 27 Sep 2021
Price :
$35
*
At a glance
- Drugs BAT 5906 (Primary)
- Indications Wet age-related macular degeneration
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Bio-Thera Solutions
- 22 Sep 2021 Status changed from recruiting to completed.
- 31 Oct 2018 New trial record